These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12615172)

  • 21. [Indicators of brain biogenic amine metabolism in various extrapyramidal disorders].
    Barchatowa WP; Milewska D; Wehr H
    Neurol Neurochir Pol; 1981; 15(4):381-6. PubMed ID: 6173791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reye syndrome: monoamine metabolites in ventricular fluid.
    Shaywitz BA; Venes J; Cohen DJ; Bowers MB
    Neurology; 1979 Apr; 29(4):467-72. PubMed ID: 571546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of cerebrospinal fluid levels of dopamine metabolites by gas chromatography.
    Watson E; Wilk S
    Psychopharmacologia; 1975 Apr; 42(1):57-6. PubMed ID: 1153623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlations between aminergic metabolites simultaneously obtained from human CSF and brain.
    Stanley M; Traskman-Bendz L; Dorovini-Zis K
    Life Sci; 1985 Oct; 37(14):1279-86. PubMed ID: 2413327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of drug-induced changes in dopamine and serotonin metabolite concentrations in the CSF of the rat.
    Mignot E; Laude D; Elghozi JL
    J Neurochem; 1984 Mar; 42(3):819-25. PubMed ID: 6198472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
    Varela M; Alexiou GA; Liakopoulou M; Papakonstantinou E; Pitsouni D; Alevizopoulos GA
    J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased homovanilic acid in cerebrospinal fluid correlates with impaired neuropsychologic function in HIV-1-infected patients.
    di Rocco A; Bottiglieri T; Dorfman D; Werner P; Morrison C; Simpson D
    Clin Neuropharmacol; 2000; 23(4):190-4. PubMed ID: 11020122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homovanillic acid and prolactin in plasma and CSF of medicated epileptic patients.
    Kalfakis N; Markianos M
    Epilepsia; 1987; 28(2):138-41. PubMed ID: 3816709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous covariability of dopamine and serotonin metabolites in human cerebrospinal fluid.
    Geracioti TD; Keck PE; Ekhator NN; West SA; Baker DG; Hill KK; Bruce AB; Wortman MD
    Biol Psychiatry; 1998 Aug; 44(3):228-33. PubMed ID: 9693394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine turnover in the intact rabbit brain: effect of pentobarbital or haloperidol.
    Barkai AI
    J Pharmacol Exp Ther; 1978 Apr; 205(1):133-40. PubMed ID: 633078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.
    Kahn RS; Davidson M; Knott P; Stern RG; Apter S; Davis KL
    Arch Gen Psychiatry; 1993 Aug; 50(8):599-605. PubMed ID: 7688208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid metabolite and nigrostriatal dopaminergic function in Parkinson's disease.
    Ishibashi K; Kanemaru K; Saito Y; Murayama S; Oda K; Ishiwata K; Mizusawa H; Ishii K
    Acta Neurol Scand; 2010 Jul; 122(1):46-51. PubMed ID: 20002007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine turnover in schizophrenia before and after haloperidol withdrawal. CSF, plasma, and urine studies.
    Beuger M; van Kammen DP; Kelley ME; Yao J
    Neuropsychopharmacology; 1996 Jul; 15(1):75-86. PubMed ID: 8797194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biogenic amine metabolites and thiamine in cerebrospinal fluid in heredo-degenerative ataxias.
    Botez MI; Young SN
    Can J Neurol Sci; 2001 May; 28(2):134-40. PubMed ID: 11383938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in cerebrospinal fluid homovanillic acid in children with Ondine's curse.
    Hedner J; Hedner T; Breese GR; Lundell KH; Lundberg D; Lundström NR; Ostergaard E; McCown TJ; Mueller RA
    Pediatr Pulmonol; 1987; 3(2):131-5. PubMed ID: 2438632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion.
    Espino A; Llorens J; Calopa M; Bartrons R; Rodriguez-Farré E; Ambrosio S
    Brain Res; 1995 Jan; 669(1):19-25. PubMed ID: 7712161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of lumbar puncture stress on dopamine and serotonin metabolites in human cerebrospinal fluid.
    Hill KK; West SA; Ekhator NN; Bruce AB; Wortman MD; Baker DG; Geracioti TD
    Neurosci Lett; 1999 Nov; 276(1):25-8. PubMed ID: 10586966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
    Stuerenburg HJ; Ganzer S; Müller-Thomsen T
    Neuro Endocrinol Lett; 2004 Dec; 25(6):435-7. PubMed ID: 15665806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ontogeny of 3,4-dihydroxyphenylacetic acid in human cerebrospinal fluid.
    Anderson GM; Riddle MA; Hoder EL; Feibel FC; Shaywitz BA; Cohen DJ
    J Neurol Neurosurg Psychiatry; 1988 Aug; 51(8):1100-2. PubMed ID: 3216215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.